Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Vanguard Group sells shares of 7 companies worth Rs 998 cr
US-based financial services company Vanguard Group on Friday bought shares of seven companies including Concord Biotech, Five-Star Business Finance and Marksans Pharma for Rs 998 crore through open ma
Vanguard Group Acquires Rs 998 Crore in Indian Companies
US-based financial services company Vanguard Group acquired shares worth Rs 998 crore in seven Indian companies via open market transactions on the NSE. Concurrently, Zurich-based UBS Group AG sold shares worth Rs 479.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale was in Concord Biotech, worth Rs 192 crore at a 15% premium.
Vanguard Group Buys Rs 998 Cr Shares in 7 Companies
Vanguard Group, a US-based financial services company, has purchased shares in seven Indian companies, including Concord Biotech and Five-Star Business Finance, for a total of Rs 998 crore.
Vanguard sells shares of 7 companies worth Rs 998 cr via block deals
US-based financial services company Vanguard Group on Friday bought shares of seven companies including Concord Biotech, Five-Star Business Finance and Marksans Pharma for Rs 998 crore through open market transactions.
Bulk deals : Vanguard Group buys shares worth Rs 1000 crore in 7 companies
On September 20, The Vanguard Group Inc A/C Vanguard Total International Stock Index Fund, The Vanguard Group Inc A/C Vanguard Emerging Markets Stock Index Fund A Series of Vanguard International, and UBS Principal Capital Asia Limited bought and sold stakes in various companies via bulk deals.
UBS Offloads Shares Worth Rs 480 Crore In Four Companies
UBS Principal Capital Asia Ltd. sold stakes in Concord Biotech Ltd., Five-Star Bus Fin Ltd., IIFL Securities Ltd. and Marksans Pharma Ltd. worth Rs 480 crore, according to the bulk deal data on the NSE. Concord had 7.4 lakh shares sold by UBS, representing a 0.7% stake at Rs 2589.86 apiece, aggregating to a total value of 191 crore.
1d
The FTSE semi-annual review will be applicable from Friday's close today.
The semi-annual FTSE changes will come into effect from Friday's (September 20) closing. This latest rejig is expected to ...
1d
on MSN
Stock market update: Nifty Pharma index advances 0.33%
Benchmark NSE Nifty50 index ended up 375.16 points at 25790.95, while the BSE Sensex stood up 1359.51 points at 84544.31.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Secret Service admits failure
Released after guilty plea
Beirut strike death toll
Rallies in North Carolina
Sesame Place suit verdict
Jurors begin deliberations
Russia threatens retaliation
$230 million crypto theft
TN abortion law blocked
Drug price challenge revived
Pandas leaving for China
Feds subpoena Schaeffer
Boeing defense chief exits
WI high court to decide
Bill to boost security OK'd
In-person voting begins
SC 1st execution in 13 years
Baby powder recalled
Hand count approved in GA
Top Hezbollah leader killed?
Sues pharmacy middlemen
FDA approves flu vaccine
144K+ Mavericks recalled
House repeals emission rules
Disney to stop using Slack
$3B for battery projects
Stein's ballot bid rejected
MS sheriff's office probe
Recalling 449K+ vehicles
1st rabies outbreak in seals
Hiker injured in bear attack
Feedback